HMGN (Hemagen Diagnostics) Float Percentage Of Total Shares Outstanding: 87.08% (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hemagen Diagnostics Float Percentage Of Total Shares Outstanding?

Hemagen Diagnostics HMGN Float Percentage Of Total Shares Outstanding is 87.08% as of Sep. 01, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hemagen Diagnostics's float shares is 13.50 Mil. Hemagen Diagnostics's total shares outstanding is 15.50 Mil. Hemagen Diagnostics's float percentage of total shares outstanding is 87.08%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hemagen Diagnostics's Insider Ownership is 9.91%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hemagen Diagnostics's Institutional Ownership is 0.00%.

Hemagen Diagnostics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Hemagen Diagnostics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=13.50/15.50
=87.08%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 87.08% mean?
Hemagen Diagnostics (HMGN) has a Float Percentage Of Total Shares Outstanding of 87.08% as of Sep. 01, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Hemagen Diagnostics and its competitors.
Is Hemagen Diagnostics' Float Percentage Of Total Shares Outstanding too high?
Hemagen Diagnostics' current Float Percentage Of Total Shares Outstanding is 87.08%.
How does Hemagen Diagnostics' Float Percentage Of Total Shares Outstanding compare to OBMP and NSPX?
Hemagen Diagnostics' Float Percentage Of Total Shares Outstanding of 87.08% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Hemagen Diagnostics and its competitors. Hemagen Diagnostics's current Float Percentage Of Total Shares Outstanding is 87.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemagen Diagnostics stock overvalued right now?
Hemagen Diagnostics (HMGN) has a current Float Percentage Of Total Shares Outstanding of 87.08%. The current Float Percentage Of Total Shares Outstanding is 87.08%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Hemagen Diagnostics (HMGN), the current Float Percentage Of Total Shares Outstanding is 87.08% as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemagen Diagnostics Business Description

Address 9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.